ReviewJournal of clinical medicine2022

Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation.

Mario Piergiulio Pezzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.